天弘恒生沪深港创新药精选50ETF发起联接C(014565)
2024-11-22
0.8065
-3.8737%
| 报告期 |
基金净值 |
股票 |
国债及现金 |
可转债 |
企业债 |
金融债 |
其他债券 |
其他投资 |
贷方余额 |
| 2024-09-30 | 7,505.77 | 304.32 | 479.77 | 0.00 | 0.00 | 0.00 | 0.00 | 261.30 | 0.00 |
| 2024-06-30 | 6,036.78 | 185.94 | 368.96 | 0.00 | 0.00 | 0.00 | 0.00 | 90.02 | 0.00 |
| 2024-03-31 | 6,500.28 | 206.43 | 384.52 | 0.00 | 0.00 | 0.00 | 0.00 | 189.52 | 0.00 |
| 2023-12-31 | 8,735.99 | 244.24 | 482.98 | 0.10 | 0.00 | 0.00 | 0.00 | 131.39 | 0.00 |
| 2023-09-30 | 6,399.68 | 174.79 | 439.94 | 0.00 | 0.00 | 0.00 | 0.00 | 185.53 | 0.00 |
| 2023-06-30 | 4,664.73 | 176.93 | 292.15 | 0.00 | 0.00 | 0.00 | 0.00 | 70.93 | 0.00 |
| 2023-03-31 | 3,243.84 | 77.01 | 334.14 | 0.00 | 0.00 | 0.00 | 0.00 | 80.86 | 0.00 |
| 2022-12-31 | 2,445.95 | 43.99 | 165.37 | 0.00 | 0.00 | 0.00 | 0.00 | 121.77 | 0.00 |
| 2022-09-30 | 2,021.67 | 24.29 | 121.82 | 0.00 | 0.00 | 0.00 | 0.00 | 21.88 | 0.00 |
